Capecitabine-docetaxel combination treatment.

about

DCA increases the antitumor effects of capecitabine in a mouse B16 melanoma allograft and a human non-small cell lung cancer A549 xenograft.A multicenter phase II trial of docetaxel and capecitabine as salvage treatment in anthracycline- and taxane-pretreated patients with metastatic breast cancer.

P2860

Q39094900-F63A9A25-17A9-4C34-9271-7A2057701182 Q40284509-76BE783B-FB22-4602-9FF5-0BEA337577CD

P2860

Capecitabine-docetaxel combination treatment.

Item

http://www.wikidata.org/entity/Q36613965

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

2006年论文

@zh

2006年论文

@zh-cn

name

Capecitabine-docetaxel combination treatment.

@ast

Capecitabine-docetaxel combination treatment.

@en

type

Item

label

Capecitabine-docetaxel combination treatment.

@ast

Capecitabine-docetaxel combination treatment.

@en

prefLabel

Capecitabine-docetaxel combination treatment.

@ast

Capecitabine-docetaxel combination treatment.

@en

P1476

Capecitabine-docetaxel combination treatment.

@en

P2093

Daniel R Budman

http://www.w3.org/2001/XMLSchema#string

Julia Mandelblat

http://www.w3.org/2001/XMLSchema#string

Tayyaba Bashir

http://www.w3.org/2001/XMLSchema#string

P2860

Gene expression profiling revealed novel mechanism of action of Taxotere and Furtulon in prostate cancer cells

Design of a novel oral fluoropyrimidine carbamate, capecitabine, which generates 5-fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissue.

Pyridoxine therapy for palmar-plantar erythrodysesthesia associated with continuous 5-fluorouracil infusion

Patterns of resistance and incomplete response to docetaxel by gene expression profiling in breast cancer patients.

Combination chemotherapy of the taxanes and antimetabolites: its use and limitations.

Prospective randomized trial of docetaxel versus mitomycin plus vinblastine in patients with metastatic breast cancer progressing despite previous anthracycline-containing chemotherapy. 304 Study Group.

Phase I, dose-finding study of capecitabine in combination with docetaxel and epirubicin as first-line chemotherapy for advanced breast cancer.

Superior survival with capecitabine plus docetaxel combination therapy in anthracycline-pretreated patients with advanced breast cancer: phase III trial results.

New horizons in treating metastatic disease.

Alternate dosing schedules for topotecan in the treatment of recurrent ovarian cancer.

P304

1169-1178

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/14737140.6.9.1169

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2006-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17020452

http://www.w3.org/2001/XMLSchema#string

Capecitabine-docetaxel combination treatment.

about

P2860

P2860

Capecitabine-docetaxel combination treatment.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698